BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15296956)

  • 21. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous penetration paradigms: the contribution of Jonathan Hadgraft.
    Lane ME
    Skin Pharmacol Physiol; 2013; 26(4-6):277-85. PubMed ID: 23921114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical, physiological, and mathematical considerations in optimizing percutaneous absorption of drugs.
    Siddiqui O
    Crit Rev Ther Drug Carrier Syst; 1989; 6(1):1-38. PubMed ID: 2665947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breaching the skin barrier--insights from molecular simulation of model membranes.
    Notman R; Anwar J
    Adv Drug Deliv Rev; 2013 Feb; 65(2):237-50. PubMed ID: 22414344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective.
    Afouna MI; Fincher TK; Khan MA; Reddy IK
    Chirality; 2003 May; 15(5):456-65. PubMed ID: 12692892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysing the skin barrier from down under.
    Grice J; Benson HA
    Skin Pharmacol Physiol; 2013; 26(4-6):254-62. PubMed ID: 23921112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin penetration enhancers.
    Lane ME
    Int J Pharm; 2013 Apr; 447(1-2):12-21. PubMed ID: 23462366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Richard Guy and his collaborators: 'crackling' the skin code.
    Delgado-Charro MB
    Skin Pharmacol Physiol; 2013; 26(4-6):302-12. PubMed ID: 23921117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Jepps OG; Dancik Y; Anissimov YG; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breaching the skin barrier through temperature modulations.
    Shahzad Y; Louw R; Gerber M; du Plessis J
    J Control Release; 2015 Mar; 202():1-13. PubMed ID: 25616160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement and prediction of the rate and extent of drug delivery into and through the skin.
    Russell LM; Guy RH
    Expert Opin Drug Deliv; 2009 Apr; 6(4):355-69. PubMed ID: 19382880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.